 | • レポートコード：MRC309Z8012 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の獣医用ワクチンアジュバントの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の獣医用ワクチンアジュバント市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 獣医用ワクチンアジュバントの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 獣医用ワクチンアジュバント市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・乳化補助剤、ミネラル補助剤、その他 用途別セグメント ・家畜ワクチン、愛玩動物ワクチン 主要な市場プレーヤー ・SEPPIC、SDA BIO、Croda、SPI Pharma、Phibro Animal Health、Vertellus 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、獣医用ワクチンアジュバント製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な獣医用ワクチンアジュバントメーカーの企業概要、2019年～2022年までの獣医用ワクチンアジュバントの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な獣医用ワクチンアジュバントメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別獣医用ワクチンアジュバントの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの獣医用ワクチンアジュバントの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での獣医用ワクチンアジュバント市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および獣医用ワクチンアジュバントの産業チェーンを掲載しています。 ・第14、15章では、獣医用ワクチンアジュバントの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 獣医用ワクチンアジュバントの概要 - 種類別分析（2018年vs2022年vs2029年）：乳化補助剤、ミネラル補助剤、その他 - 用途別分析（2018年vs2022年vs2029年）：家畜ワクチン、愛玩動物ワクチン - 世界の獣医用ワクチンアジュバント市場規模・予測 - 世界の獣医用ワクチンアジュバント生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - SEPPIC、SDA BIO、Croda、SPI Pharma、Phibro Animal Health、Vertellus ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：乳化補助剤、ミネラル補助剤、その他 ・用途別分析2018年-2029年：家畜ワクチン、愛玩動物ワクチン ・獣医用ワクチンアジュバントの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・獣医用ワクチンアジュバントのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・獣医用ワクチンアジュバントのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・獣医用ワクチンアジュバントの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・獣医用ワクチンアジュバントの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Veterinary Vaccine Adjuvants market size was valued at USD 312.5 million in 2022 and is forecast to a readjusted size of USD 490.2 million by 2029 with a CAGR of 6.6% during review period.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.
North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.
The Global Info Research report includes an overview of the development of the Veterinary Vaccine Adjuvants industry chain, the market status of Livestock Vaccines (Emulsion Adjuvants, Mineral Adjuvants), Companion Animals Vaccines (Emulsion Adjuvants, Mineral Adjuvants), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Veterinary Vaccine Adjuvants.
Regionally, the report analyzes the Veterinary Vaccine Adjuvants markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Veterinary Vaccine Adjuvants market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Veterinary Vaccine Adjuvants market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Veterinary Vaccine Adjuvants industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K L), revenue generated, and market share of different by Type (e.g., Emulsion Adjuvants, Mineral Adjuvants).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Veterinary Vaccine Adjuvants market.
Regional Analysis: The report involves examining the Veterinary Vaccine Adjuvants market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Veterinary Vaccine Adjuvants market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Veterinary Vaccine Adjuvants:
Company Analysis: Report covers individual Veterinary Vaccine Adjuvants manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Veterinary Vaccine Adjuvants This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Livestock Vaccines, Companion Animals Vaccines).
Technology Analysis: Report covers specific technologies relevant to Veterinary Vaccine Adjuvants. It assesses the current state, advancements, and potential future developments in Veterinary Vaccine Adjuvants areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Veterinary Vaccine Adjuvants market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Veterinary Vaccine Adjuvants market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Market segment by Application
Livestock Vaccines
Companion Animals Vaccines
Major players covered
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Veterinary Vaccine Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Veterinary Vaccine Adjuvants, with price, sales, revenue and global market share of Veterinary Vaccine Adjuvants from 2018 to 2023.
Chapter 3, the Veterinary Vaccine Adjuvants competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Veterinary Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Vaccine Adjuvants.
Chapter 14 and 15, to describe Veterinary Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Veterinary Vaccine Adjuvants
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Veterinary Vaccine Adjuvants Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Emulsion Adjuvants
1.3.3 Mineral Adjuvants
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Veterinary Vaccine Adjuvants Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Livestock Vaccines
1.4.3 Companion Animals Vaccines
1.5 Global Veterinary Vaccine Adjuvants Market Size & Forecast
1.5.1 Global Veterinary Vaccine Adjuvants Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Veterinary Vaccine Adjuvants Sales Quantity (2018-2029)
1.5.3 Global Veterinary Vaccine Adjuvants Average Price (2018-2029)
2 Manufacturers Profiles
2.1 SEPPIC
2.1.1 SEPPIC Details
2.1.2 SEPPIC Major Business
2.1.3 SEPPIC Veterinary Vaccine Adjuvants Product and Services
2.1.4 SEPPIC Veterinary Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 SEPPIC Recent Developments/Updates
2.2 SDA BIO
2.2.1 SDA BIO Details
2.2.2 SDA BIO Major Business
2.2.3 SDA BIO Veterinary Vaccine Adjuvants Product and Services
2.2.4 SDA BIO Veterinary Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 SDA BIO Recent Developments/Updates
2.3 Croda
2.3.1 Croda Details
2.3.2 Croda Major Business
2.3.3 Croda Veterinary Vaccine Adjuvants Product and Services
2.3.4 Croda Veterinary Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Croda Recent Developments/Updates
2.4 SPI Pharma
2.4.1 SPI Pharma Details
2.4.2 SPI Pharma Major Business
2.4.3 SPI Pharma Veterinary Vaccine Adjuvants Product and Services
2.4.4 SPI Pharma Veterinary Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 SPI Pharma Recent Developments/Updates
2.5 Phibro Animal Health
2.5.1 Phibro Animal Health Details
2.5.2 Phibro Animal Health Major Business
2.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Product and Services
2.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Phibro Animal Health Recent Developments/Updates
2.6 Vertellus
2.6.1 Vertellus Details
2.6.2 Vertellus Major Business
2.6.3 Vertellus Veterinary Vaccine Adjuvants Product and Services
2.6.4 Vertellus Veterinary Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Vertellus Recent Developments/Updates
3 Competitive Environment: Veterinary Vaccine Adjuvants by Manufacturer
3.1 Global Veterinary Vaccine Adjuvants Sales Quantity by Manufacturer (2018-2023)
3.2 Global Veterinary Vaccine Adjuvants Revenue by Manufacturer (2018-2023)
3.3 Global Veterinary Vaccine Adjuvants Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Veterinary Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Veterinary Vaccine Adjuvants Manufacturer Market Share in 2022
3.4.2 Top 6 Veterinary Vaccine Adjuvants Manufacturer Market Share in 2022
3.5 Veterinary Vaccine Adjuvants Market: Overall Company Footprint Analysis
3.5.1 Veterinary Vaccine Adjuvants Market: Region Footprint
3.5.2 Veterinary Vaccine Adjuvants Market: Company Product Type Footprint
3.5.3 Veterinary Vaccine Adjuvants Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Veterinary Vaccine Adjuvants Market Size by Region
4.1.1 Global Veterinary Vaccine Adjuvants Sales Quantity by Region (2018-2029)
4.1.2 Global Veterinary Vaccine Adjuvants Consumption Value by Region (2018-2029)
4.1.3 Global Veterinary Vaccine Adjuvants Average Price by Region (2018-2029)
4.2 North America Veterinary Vaccine Adjuvants Consumption Value (2018-2029)
4.3 Europe Veterinary Vaccine Adjuvants Consumption Value (2018-2029)
4.4 Asia-Pacific Veterinary Vaccine Adjuvants Consumption Value (2018-2029)
4.5 South America Veterinary Vaccine Adjuvants Consumption Value (2018-2029)
4.6 Middle East and Africa Veterinary Vaccine Adjuvants Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Veterinary Vaccine Adjuvants Sales Quantity by Type (2018-2029)
5.2 Global Veterinary Vaccine Adjuvants Consumption Value by Type (2018-2029)
5.3 Global Veterinary Vaccine Adjuvants Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Veterinary Vaccine Adjuvants Sales Quantity by Application (2018-2029)
6.2 Global Veterinary Vaccine Adjuvants Consumption Value by Application (2018-2029)
6.3 Global Veterinary Vaccine Adjuvants Average Price by Application (2018-2029)
7 North America
7.1 North America Veterinary Vaccine Adjuvants Sales Quantity by Type (2018-2029)
7.2 North America Veterinary Vaccine Adjuvants Sales Quantity by Application (2018-2029)
7.3 North America Veterinary Vaccine Adjuvants Market Size by Country
7.3.1 North America Veterinary Vaccine Adjuvants Sales Quantity by Country (2018-2029)
7.3.2 North America Veterinary Vaccine Adjuvants Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Veterinary Vaccine Adjuvants Sales Quantity by Type (2018-2029)
8.2 Europe Veterinary Vaccine Adjuvants Sales Quantity by Application (2018-2029)
8.3 Europe Veterinary Vaccine Adjuvants Market Size by Country
8.3.1 Europe Veterinary Vaccine Adjuvants Sales Quantity by Country (2018-2029)
8.3.2 Europe Veterinary Vaccine Adjuvants Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Veterinary Vaccine Adjuvants Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Veterinary Vaccine Adjuvants Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Veterinary Vaccine Adjuvants Market Size by Region
9.3.1 Asia-Pacific Veterinary Vaccine Adjuvants Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Veterinary Vaccine Adjuvants Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Veterinary Vaccine Adjuvants Sales Quantity by Type (2018-2029)
10.2 South America Veterinary Vaccine Adjuvants Sales Quantity by Application (2018-2029)
10.3 South America Veterinary Vaccine Adjuvants Market Size by Country
10.3.1 South America Veterinary Vaccine Adjuvants Sales Quantity by Country (2018-2029)
10.3.2 South America Veterinary Vaccine Adjuvants Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Veterinary Vaccine Adjuvants Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Veterinary Vaccine Adjuvants Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Veterinary Vaccine Adjuvants Market Size by Country
11.3.1 Middle East & Africa Veterinary Vaccine Adjuvants Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Veterinary Vaccine Adjuvants Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Veterinary Vaccine Adjuvants Market Drivers
12.2 Veterinary Vaccine Adjuvants Market Restraints
12.3 Veterinary Vaccine Adjuvants Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Veterinary Vaccine Adjuvants and Key Manufacturers
13.2 Manufacturing Costs Percentage of Veterinary Vaccine Adjuvants
13.3 Veterinary Vaccine Adjuvants Production Process
13.4 Veterinary Vaccine Adjuvants Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Veterinary Vaccine Adjuvants Typical Distributors
14.3 Veterinary Vaccine Adjuvants Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer